RLAY - relaytx.com Company Cash on Hand

Official company branding of Relay Pharma (RLAY)

The GURU.Markets terminal displays a chart of the cash position, where the 0.84 mark indicates the current state of liquidity. The price action of the cash liquidity metric correlates with expectations for Phase 2 data from the Dynamo platform. Relay Therapeutics (RLAY) relies on a synthesis of biophysics and IT to identify vulnerable proteins, while diversification across various cancer mutations protects the business from regulatory risks.

Relay Therapeutics Inc - RLAY Company Total Cash Amount (period 07/04/2022 - 11/21/2026)

Summary analytical data breakdowns for Relay Therapeutics Inc (RLAY)

Fundamental valuation:Relay Corp
Brand item of Relay Therapeutics, Inc.

This indicator captures the aggregate of highly liquid assets to assess the company's ability to instantaneously meet financial obligations and fund development. By analyzing the cash position of Relay Therapeutics (RLAY), an investor can see the impact of advances from Roche and royalties from the use of the Dynamite AI platform, which determines the margin of safety for Relay Therapeutics (RLAY) in the development of targeted oncology drugs.